BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6114857)

  • 1. Portal somatostatin responds to intragastric glucose: effects of streptozotocin diabetes.
    Kazumi T; Yoshino G; Utsumi M; Ishihara K; Makimura H; Baba S
    Endocrinol Jpn; 1980 Dec; 27(6):675-8. PubMed ID: 6114857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin concentration responds to arginine in portal plasma: effects of fasting, streptozotocin diabetes, and insulin administration in diabetic rats.
    Kazumi T; Utsumi M; Yoshino G; Ishihara K; Hirose Y; Makimura H; Baba S
    Diabetes; 1980 Jan; 29(1):71-3. PubMed ID: 6103853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased blood somatostatin concentration in streptozotocin diabetic rats.
    Patel YC; Wheatley T; Zingg HH
    Life Sci; 1980 Oct; 27(17):1563-70. PubMed ID: 6108496
    [No Abstract]   [Full Text] [Related]  

  • 4. Concentration and secretion of gastric somatostatin in streptozotocin-diabetic rats.
    Chiba T; Kadowaki S; Taminato T; Abe H; Chihara K; Matsukura S; Goto Y; Seino Y; Fujita T
    Diabetes; 1981 Mar; 30(3):188-91. PubMed ID: 6110599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
    Kurose T; Tsuda K; Ishida H; Tsuji K; Okamoto Y; Tsuura Y; Kato S; Usami M; Imura H; Seino Y
    Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M; Kronheim S; Pimstone B; Shapiro B
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptozotocin diabetes in the monkey: plasma levels of glucose, insulin, glucagon, and somatostatin, with corresponding morphometric analysis of islet endocrine cells.
    Jones CW; Reynolds WA; Hoganson GE
    Diabetes; 1980 Jul; 29(7):536-46. PubMed ID: 6103856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation and conversion of somatostatin in normal and diabetic rats in vivo and in vitro.
    Seno M; Tsuda K; Kitano N; Takeda J; Fukumoto H; Koh G; Imura H; Taminato T; Seino Y
    Can J Physiol Pharmacol; 1988 Jan; 66(1):55-60. PubMed ID: 2897235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats.
    Yue JT; Burdett E; Coy DH; Giacca A; Efendic S; Vranic M
    Diabetes; 2012 Jan; 61(1):197-207. PubMed ID: 22106159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of hepatic portal circulation for insulin action in streptozotocin-diabetic rats transplanted with fetal pancreases.
    Brown J; Mullen Y; Clark WR; Molnar IG; Heininger D
    J Clin Invest; 1979 Dec; 64(6):1688-94. PubMed ID: 159316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of increased gastric somatostatin in streptozotocin-diabetic rats by whole pancreas transplantation.
    Chiba T; Taminato T; Kadowaki S; Chihara K; Matsukura S; Nozawa M; Seino Y; Fujita T
    Diabetes; 1981 Sep; 30(9):724-7. PubMed ID: 6114886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucose on somatostatin secretion from isolated pancreatic islets of normal and streptozotocin-diabetic rats.
    Kanatsuka A; Makino H; Matsushima Y; Osegawa M; Kasanuki J; Miyahira M; Yamamoto M; Kumagai A
    Endocrinology; 1981 Aug; 109(2):652-7. PubMed ID: 6113954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of physical training in rats with a mild streptozotocin-induced diabetes mellitus.
    Tancrède G; Rousseau-Migneron S; Nadeau A
    Diabetes; 1982 May; 31(5 Pt 1):406-9. PubMed ID: 6759257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in somatostatin concentration in pancreas and other tissues of streptozotocin diabetic rats.
    Patel YC; Cameron DP; Bankier A; Malaisse-Lagae F; Ravazzola M; Studer P; Orci L
    Endocrinology; 1978 Sep; 103(3):917-23. PubMed ID: 154402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated portal and peripheral blood concentration of immunoreactive somatostatin in spontaneously diabetic (BBL) Wistar rats: suppression with insulin.
    Patel YC; Wheatley T; Malaisse-Lagae F; Orci L
    Diabetes; 1980 Sep; 29(9):757-61. PubMed ID: 6108276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superactive somatostatin analog decreases plasma glucose and glucagon levels in diabetic rats.
    Karashima T; Schally AV
    Peptides; 1988; 9(3):561-5. PubMed ID: 2901737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a heavy exercise program on the distribution of pancreatic hormones in the streptozotocin-induced diabetic rat.
    Howarth FC; Marzouqi FM; Al Saeedi AM; Hameed RS; Adeghate E
    JOP; 2009 Sep; 10(5):485-91. PubMed ID: 19734622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats.
    Qinna NA; Badwan AA
    Drug Des Devel Ther; 2015; 9():2515-25. PubMed ID: 26005328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin, gastrin-releasing peptide and gastrin in the stomach of rats with streptozotocin-induced diabetes and insulinoma.
    Flatt PR; Bailey CJ; Conlon JM
    J Nutr; 1991 Sep; 121(9):1414-7. PubMed ID: 1679127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats.
    Inouye K; Shum K; Chan O; Mathoo J; Matthews SG; Vranic M
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1369-79. PubMed ID: 12006368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.